Department of Medicine Archive — Page 97 of 120

January 19, 2017

Digestive Disease Research Center lands major grant

The Vanderbilt Digestive Disease Research Center (VDDRC) celebrates its 15th anniversary this year with a third consecutive five-year renewal of its federal research grant.

By Jill Clendening
Close-up of a woolen knitted texture (blue)
January 19, 2017

Surprising finding by VU team sheds light on fibrotic disease

Integrins are membrane proteins made up of combinations of different “alpha” and “beta” subunits that enable cells throughout the body to interact with their surroundings.

By Bill Snyder
January 19, 2017

Study to track diabetes drug’s ability to also treat asthma

Investigators in the Division of Allergy, Pulmonary, and Critical Care Medicine and the Division of Diabetes, Endocrinology, and Metabolism recently received a $1.25 million grant from the National Institute of Allergy and Infectious Diseases.

By Vanderbilt Health News
Clinical and translational research at Vanderbilt will be funded over the next five years, thanks to a $46 million renewal grant from the National Center for Advancing Translational Sciences. (Mary Donaldson/Vanderbilt)
January 5, 2017

Department of Medicine’s NIH funding swells

Vanderbilt University School of Medicine has long been recognized as a national leader in biomedical research. Nowhere is this more evident than in the school’s Department of Medicine, which, during the 2016 federal fiscal year that ended Sept. 30, broke another record.

By Bill Snyder
January 5, 2017

Rothman named AACH president-elect

Russell Rothman, M.D., professor of Medicine, Pediatrics and Health Policy, Vice President for Population Health Research, and director of the Vanderbilt Center for Health Services Research, has been named president-elect of the American Academy on Communication in Healthcare (AACH). He will serve as president beginning in January 2018.

By Nancy Humphrey
December 21, 2016

Daughter’s rare adverse drug reaction inspires family’s donation

Last year Paul and Wanpen Anderson of Champaign, Illinois, were preparing to celebrate the Christmas holidays with their two children when their 22-year-old daughter, Angela, developed a rare adverse drug reaction called SJS/TEN.

By Bill Snyder